CEOCFO MOBILE  |  CURRENT ISSUE  |  INDEX  |  CONTACT  |  CEOCFO-SERVICES  | HOME

CANNABIS

CEOCFO-Members Login

2018

CEOCFO MAGAZINE


Business Services   Healthcare   Technology   Cannabis  Financial   Capital   Resources   Public Companies    Government Services    Clean Tech    Industrial    Canadian   Global


 




 

 



Offering a Sublingual Elixir Spray with No Second-Hand Smoke and Edible Cannabis Powders providing an alternative to smoking for Many Patients The Hydropothecary is bring Innovative Products to a Highly Regulated Market

The Hydropothecary Corporation
THCX (CVE)

Sébastien St. Louis, Co-Founder & Chief Executive Officer

www.thehydropothecary.com  Print Version - PDF  Mobile Download - PDF



 

Utilizing Cannabinoids to provide Safe and Effective Products for both the Medical and Adult-use Markets with the industry’s first Drug Preparation Premises facility under construction
TerrAscend Corp. (CNSX:TER)

Michael Nashat, President & CEO

www.TerrAscend.com  Print Version - PDF  Mobile Download - PDF


 

 

Now focused on making Full Acquisitions of Cannabis Companies and Assets in the State of California and being an Active Operator, CannaRoyalty is positioned to take advantage of this Growing Industry and Generate True Shareholder Value
 

CannaRoyalty
Afzal Hasan, Executive VP of Corporate Development

Print Version - PDF  Mobile Download - PDF






A Health Canada Licensed Producer of Medical Cannabis allowing them to Cultivate, Grow and Sell Medical Marijuana and Oils to Patients Across the Country

Emerald Health Therapeutics, Inc.
(TSXV: EMH; OTCQX: EMHTF)

Chris Wagner, Chief Executive Officer

http://emeraldhealth.ca/  Print Version - PDF  Mobile Download - PDF



 

 

Developing Bio-engineered Medicines using Cannabinoid Molecules in a Pro-drug of THC to offer a Revolutionary Treatment for Glaucoma Patients with a Dual Benefit of Lowering Intraocular Pressure and Providing Neuroprotection
 

Nemus Bioscience
Dr. Brian Murphy, MD, MPH, MBA, Chief Executive Officer; Chief Medical Officer, Director

http://www.nemusbioscience.com/home/default.aspx
Print Version - PDF  Mobile Download - PDF





Focused on Plant-based Medicine, GB Sciences, Inc. has developed one of the finest Cultivation Facilities in the US and a suite of Cannabinoid-based Compounds showing promise in the Treatment of Parkinson’s Disease and Neuropathic Pain
 

Growblox Life Sciences, LLC (wholly-owned subsidiary)
GB Sciences, Inc. (OTCQB: GBLX) (parent company)

John Poss, Chairman and CEO

www.gbsciences.com  Print Version - PDF  Mobile Download - PDF



 



















 

 

   

 

 

Algae Dynamics Corp. (OTCQB: ADYNF)
Cannabis and Algae Oil used in Developing Unique Health Products and Pharmaceuticals Cannabis Oil Medicine
 

CannaRoyalty

Now focused on making Full Acquisitions of Cannabis Companies and Assets in the State of California and being an Active Operator, CannaRoyalty is positioned to take advantage of this Growing Industry and Generate True Shareholder Value

Emerald Health Therapeutics, Inc.
(TSXV: EMH; OTCQX: EMHTF)

A Health Canada Licensed Producer of Medical Cannabis allowing them to Cultivate, Grow and Sell Medical Marijuana and Oils to Patients Across the Country
 



Growblox Life Sciences, LLC (wholly-owned subsidiary)
GB Sciences, Inc. (OTCQB: GBLX) (parent company)
Focused on Plant-based Medicine, GB Sciences, Inc. has developed one of the finest Cultivation Facilities in the US and a suite of Cannabinoid-based Compounds showing promise in the Treatment of Parkinson’s Disease and Neuropathic Pain

 



Nemus Bioscience

Developing Bio-engineered Medicines using Cannabinoid Molecules in a Pro-drug of THC to offer a Revolutionary Treatment for Glaucoma Patients with a Dual Benefit of Lowering Intraocular Pressure and Providing Neuroprotection

TerrAscend Corp. (CNSX:TER)
Utilizing Cannabinoids to provide Safe and Effective Products for both the Medical and Adult-use Markets with the industry’s first Drug Preparation Premises facility under construction


The Hydropothecary Corporation
THCX (CVE)

Offering a Sublingual Elixir Spray with No Second-Hand Smoke and Edible Cannabis Powders providing an alternative to smoking for Many Patients The Hydropothecary is bring Innovative Products to a Highly Regulated Market


 

 

disclaimers

© CEOCFO Magazine - All rights reserved

Any reproduction or further distribution of this article without the express written consent of CEOCFOinterviews.com is prohibited.

Healthcare, Financial and Business News, Investor Information, CEO Interviews, Healthcare Stock, Medical Diagnostic Stock, Drug Development Stock, Medical Device Stock, Regenerative Medicing Stock, Wound Care Companies, Health and Wellness Companies